Literature DB >> 10602502

Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases.

N Ikematsu1, Y Yoshida, J Kawamura-Tsuzuku, M Ohsugi, M Onda, M Hirai, J Fujimoto, T Yamamoto.   

Abstract

Human cDNAs encoding a novel member of Tob/BTG1 anti-proliferative family proteins were cloned. The putative protein product termed Tob2 consisted of 344 amino acids with high similarity to the Tob protein. The tob2 mRNA was 4.1 kb long and was ubiquitously expressed in human adult tissues, as was revealed by Northern blot hybridization. However, further in situ hybridization analysis showed a characteristic expression of the tob2 mRNA in oocytes, suggesting a unique role of Tob2 in oogenesis. Like the Tob protein, Tob2 inhibited cell cycle progression from the G0/G1 to S phases. Intriguingly, the amino-terminal half of Tob2 as well as that of Tob was associated with a human homologue of yeast Caf1, a component of the CCR4 transcription factor complex. Moreover, Caf1 was associated with cyclin dependent kinases. These data suggested that both Tob and Tob2 were involved in cell cycle regulation through their interaction with Caf1. Finally, the tob2 gene was mapped to human chromosome 22q13.1-q13.31.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602502     DOI: 10.1038/sj.onc.1203193

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

Review 1.  Metabolic regulation of T cell differentiation and function.

Authors:  Benjamin V Park; Fan Pan
Journal:  Mol Immunol       Date:  2015-08-12       Impact factor: 4.407

2.  xBtg-x regulates Wnt/beta-Catenin signaling during early Xenopus development.

Authors:  Oliver Wessely; James I Kim; Uyen Tran; Luis Fuentealba; E M De Robertis
Journal:  Dev Biol       Date:  2005-07-01       Impact factor: 3.582

Review 3.  Bone morphogenetic proteins and their antagonists.

Authors:  Elisabetta Gazzerro; Ernesto Canalis
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

4.  Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylases.

Authors:  Yuji Funakoshi; Yusuke Doi; Nao Hosoda; Naoyuki Uchida; Masanori Osawa; Ichio Shimada; Masafumi Tsujimoto; Tsutomu Suzuki; Toshiaki Katada; Shin-ichi Hoshino
Journal:  Genes Dev       Date:  2007-12-01       Impact factor: 11.361

5.  ANA deficiency enhances bone morphogenetic protein-induced ectopic bone formation via transcriptional events.

Authors:  Kentaro Miyai; Mitsuhiro Yoneda; Urara Hasegawa; Sayaka Toita; Yayoi Izu; Hiroaki Hemmi; Tadayoshi Hayata; Yoichi Ezura; Shuki Mizutani; Kohei Miyazono; Kazunari Akiyoshi; Tadashi Yamamoto; Masaki Noda
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

6.  Biological role of the two overlapping poly(A)-binding protein interacting motifs 2 (PAM2) of eukaryotic releasing factor eRF3 in mRNA decay.

Authors:  Masanori Osawa; Nao Hosoda; Tamiji Nakanishi; Naoyuki Uchida; Tomomi Kimura; Shunsuke Imai; Asako Machiyama; Toshiaki Katada; Shin-ichi Hoshino; Ichio Shimada
Journal:  RNA       Date:  2012-09-27       Impact factor: 4.942

7.  hCAF1/CNOT7 regulates interferon signalling by targeting STAT1.

Authors:  Clément Chapat; Chloé Kolytcheff; Muriel Le Romancer; Didier Auboeuf; Pierre De La Grange; Kamel Chettab; Stéphanie Sentis; Laura Corbo
Journal:  EMBO J       Date:  2013-02-05       Impact factor: 11.598

8.  The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation.

Authors:  Akhmed Aslam; Saloni Mittal; Frederic Koch; Jean-Christophe Andrau; G Sebastiaan Winkler
Journal:  Mol Biol Cell       Date:  2009-07-15       Impact factor: 4.138

9.  Tob1 is a constitutively expressed repressor of liver regeneration.

Authors:  Karen J Ho; Nhue L Do; Hasan H Otu; Martin J Dib; Xianghui Ren; Keiichi Enjyoji; Simon C Robson; Ernest F Terwilliger; Seth J Karp
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

10.  Tob2 inhibits peroxisome proliferator-activated receptor γ2 expression by sequestering Smads and C/EBPα during adipocyte differentiation.

Authors:  Akinori Takahashi; Masahiro Morita; Kazumasa Yokoyama; Toru Suzuki; Tadashi Yamamoto
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.